References
- Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Hsiao K. Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science. 1997;276(5321):2045–47. doi:10.1126/science.276.5321.2045.
- Healy DG, Abou-Sleiman PM, Wood NW. PINK, PANK, or PARK? A clinicians’ guide to familial parkinsonism. Lancet Neurol. 2004;3(11):652–62. doi:10.1016/S1474-4422(04)00905-6.
- Hardy J, Cookson MR, Singleton A. Genes and parkinsonism. Lancet Neurol. 2003;2(4):221–8. doi:10.1016/S1474-4422(03)00350-8.
- Winner B, Jappelli R, Maji SK, Desplats PA, Boyer L, Aigner S, et al. In vivo demonstration that α-synuclein oligomers are toxic. Proc Natl Acad Sci. 2011;108(10):4194–9. doi: 10.1073/pnas.1100976108.
- Karpinar DP, Balija MBG, Kügler S, Opazo F, Rezaei-Ghaleh N, Wender N, et al. Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson’s disease models. EMBO J. 2009;28(20):3256–68. doi:10.1038/emboj.2009.257.
- Caughey B, Lansbury PT. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from The Innocent Bystanders. Annu Rev Neurosci. 2003;26:267–98. doi:10.1146/annurev.neuro.26.010302.081142.
- Danzer KM, Haasen D, Karow AR, Moussaud S, Habeck M, Giese A, et al. Different species of α-synuclein oligomers induce Calcium Influx and seeding. J Neurosci. 2007;27(34):9220–32. doi:10.1523/JNEUROSCI.2617-07.2007.
- Devi L, Raghavendran V, Prabhu BM, Avadhani NG, Anandatheerthavarada HK. Mitochondrial import and accumulation of α-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J Biol Chem. 2008;283(14):9089–100. doi:10.1074/jbc.M710012200.
- Piccoli C, Sardanelli A, Scrima R, Ripoli M, Quarato G, D’Aprile A, et al. Mitochondrial respiratory dysfunction in familiar Parkinsonism associated with PINK1 mutation. Neurochem Res. 2008;33(12):2565–74. doi:10.1007/s11064-008-9729-2.
- Hirsch EC, Breidert T, Rousselet E, Hunot S, Hartmann A, Michel PP. The role of glial reaction and inflammation in Parkinson’s disease. Ann N Y Acad Sci. 2003;991:214–28. doi:10.1111/j.1749-6632.2003.tb07478.x.
- Hoozemans JJM, van Haastert ES, Eikelenboom P, de Vos RAI, Rozemuller JM, Scheper W. Activation of the unfolded protein response in Parkinson’s disease. Biochem Biophys Res Commun. 2007;354(3):707–11. doi:10.1016/j.bbrc.2007.01.043.
- Conn KJ, Gao W, McKee A, Lan MS, Ullman MD, Eisenhauer PB, et al. Identification of the protein disulfide isomerase family member PDIp in experimental Parkinson’s disease and Lewy body pathology. Brain Res. 2004;1022(1-2):164–72. doi:10.1016/j.brainres.2004.07.026.
- Kaufman RJ. Coordination of gene transcriptional and translational controls stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev. 1999;13:1211–33. doi:10.1101/gad.13.10.1211.
- Mor DE, Tsika E, Mazzulli JR, Gould NS, Kim H, Daniels MJ, et al. Dopamine induces soluble α-synuclein oligomers and nigrostriatal degeneration. Nat Neurosci. 2017;20(11):1560–8. doi:10.1038/nn.4641.
- Yamakawa K, Izumi Y, Takeuchi H, Yamamoto N, Kume T, Akaike A, et al. Dopamine facilitates α-synuclein oligomerization in human neuroblastoma SH-SY5Y cells. Biochem Biophys Res Commun. 2010;391(1):129–34. doi:10.1016/j.bbrc.2009.11.015.
- Harding HP, Novoa I, Zhang Y, Wek R, Schapira M, Ron D. Regulated translation initiation controls stress-induced gene expression in Mammalian cells. Mol Cell. 2000;6(5):1099–108. doi:10.1016/S1097-2765(00)00108-8.
- Ameri K, Harris AL. Activating transcription factor 4. Int J Biochem Cell Biol. 2008;40(1):14–21. doi:10.1016/j.biocel.2007.01.020.
- Yamamoto K, Sato T, Matsui T, Sato M, Okada T, Yoshida H, et al. Transcriptional induction of Mammalian ER Quality control proteins Is mediated by Single or Combined action of ATF6α and XBP1. Dev Cell. 2007;13(3):365–76. doi:10.1016/j.devcel.2007.07.018.
- Calfon M, Zeng H, Urano F, Till JH, Hubbard SR, Harding HP, et al. IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA. Nature. 2002;415(6867):92–96. doi:10.1038/nature01193 doi: 10.1038/415092a
- Lee A-H, Iwakoshi NN, Glimcher LH. XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response. Mol Cell Biol. 2003;23(21):7448–59. doi:10.1128/MCB.23.21.7448 doi: 10.1128/MCB.23.21.7448-7459.2003
- Fomby P, Cherlin AJ. Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat Cell Biol. 2011;72(2):181–204. doi:10.1038/nature13314.A.
- Urano F, Wang X, Bertolotti A, Zhang Y, Chung P, Harding HP, et al. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science. 2000;287(5453):664–6. doi:10.1126/science.287.5453.664.
- Ogata M, Hino S, Saito A, Morikawa K, Kondo S, Kanemoto S, et al. Autophagy is activated for cell survival after endoplasmic reticulum stress. Mol Cell Biol. 2006;26(24):9220–31. doi:10.1128/MCB.01453-06.
- Sugeno N, Takeda A, Hasegawa T, Kobayashi M, Kikuchi A, Mori F, et al. Serine 129 phosphorylation of α-synuclein induces unfolded protein response-mediated cell death. J Biol Chem. 2008;283(34):23179–88. doi:10.1074/jbc.M802223200.
- Bellucci A, Navarria L, Zaltieri M, Falarti E, Bodei S, Sigala S, et al. Induction of the unfolded protein response by α-synuclein in experimental models of Parkinson’s disease. J Neurochem. 2011;116(4):588–605. doi:10.1111/j.1471-4159.2010.07143.x.
- Holtz WA, O’Malley KL. Parkinsonian mimetics induce aspects of unfolded protein response in death of dopaminergic neurons. J Biol Chem. 2003;278(21):19367–77. doi:10.1074/jbc.M211821200.
- Ryu EJ, Harding HP, Angelastro JM, Vitolo O V, Ron D, Greene LA. Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson’s disease. J Neurosci. 2002;22(24):10690–8. doi: 10.1523/JNEUROSCI.22-24-10690.2002
- Yokota T, Sugawara K, Ito K, Takahashi R, Ariga H, Mizusawa H. Down regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition. Biochem Biophys Res Commun. 2003;312(4):1342–8. doi:10.1016/j.bbrc.2003.11.056.
- Wu L, Tian YY, Shi JP, Xie W, Shi J-Q, Lu J, et al. Inhibition of endoplasmic reticulum stress is involved in the neuroprotective effects of candesartan cilexitil in the rotenone rat model of Parkinson’s disease. Neurosci Lett. 2013;548:50–55. doi:10.1016/j.neulet.2013.06.008.
- Sado M, Yamasaki Y, Iwanaga T, Onaka Y, Ibuki T, Nishihara S, et al. Protective effect against Parkinson’s disease-related insults through the activation of XBP1. Brain Res. 2009;1257:16–24. doi:10.1016/j.brainres.2008.11.104.
- Gorbatyuk MS, Shabashvili A, Chen W, Meyers C, Sullivan LF, Salganik M, et al. Glucose regulated protein 78 diminishes α-synuclein neurotoxicity in a rat model of Parkinson disease. Mol Ther. 2012;20(7):1327–37. doi:10.1038/mt.2012.28.
- Povichit N, Phrutivorapongkul A, Suttajit M, Leelapornpisid P. Antiglycation and antioxidant activities of oxyresveratrol extracted from the heartwood of artocarpus lakoocha roxb. Maejo Int J Sci Technol. 2010;4(3):454–61.
- Lorenz P, Roychowdhury S, Engelmann M, Wolf G, Horn TFW. Oxyresveratrol and resveratrol are potent antioxidants and free radical scavengers: effect on nitrosative and oxidative stress derived from microglial cells. Nitric Oxide - Biol Chem. 2003;9(2):64–76. doi:10.1016/j.niox.2003.09.005.
- Chao J, Yu M, Ho Y, Wang M, Chang RC. Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine toxicity. Free Radic Biol Med. 2008;45:1019–26. doi:10.1016/j.freeradbiomed.2008.07.002.
- Jin F, Wu Q, Lu Y-F, Gong Q-H, Shi J-S. Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson’s disease in rats. Eur J Pharmacol. 2008;600(1-3):78–82. doi:10.1016/j.ejphar.2008.10.005.
- Khan MM, Ahmad A, Ishrat T, Khan MB, Hoda MN, Khuwaja G, et al. Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson’s disease. Brain Res. 2010;1328:139–51. doi: 10.1016/j.brainres.2010.02.031
- Vamsi KG, Haifan L. Endoplasmic reticulum stress–induced cell death in dopaminergic cells: effect of resveratrol. Nat Rev Mol Cell Biol. 2009;10(2) (1):116–25. doi:10.1038/nrm2621.
- Chao J, Li H, Cheng KW, Yu MS, Chang RCC, Wang M. Protective effects of pinostilbene, a resveratrol methylated derivative, against 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells. J Nutr Biochem. 2010;21(6):482–9. doi:10.1016/j.jnutbio.2009.02.004.
- Oslowski CM, Urano F. Measuring ER stress and the unfolded protein response using mammalian tissue culture system. Methods Enzymol. 2011;490:71–92. doi: 10.1016/B978-0-12-385114-7.00004-0
- Ho YS, Yu MS, Lai CSW, So KF, Yuen WH, Chang RCC. Characterizing the neuroprotective effects of alkaline extract of Lycium barbarum on β-amyloid peptide neurotoxicity. Brain Res. 2007;1158(1):123–34. doi:10.1016/j.brainres.2007.04.075.
- Hung CH-L, Cheng SS-Y, Cheung Y-T, Wuwongse S, Zhang NQ, Ho Y-S, et al. A reciprocal relationship between reactive oxygen species and mitochondrial dynamics in neurodegeneration. Redox Biol. 2018;14:7–19. doi:10.1016/j.redox.2017.08.010.
- You R, Ho YS, Hung CHL, Liu Y, Huang C-X, Chan H-N, et al. Silica nanoparticles induce neurodegeneration-like changes in behavior, neuropathology, and affect synapse through MAPK activation. Part Fibre Toxicol. 2018;15(1):28. doi:10.1186/s12989-018-0263-3.
- Cohen G, Heikkila RE. Generation of Hydrogen-Peroxide, Superoxide Radical, and hydroxyl Radical by 6-hydroxydopamine, Dialuric acid, and Related Cytotoxic agents. J Biol Chem. 1974;249(8):2447–52. doi: 10.1016/S0021-9258(19)42751-8
- Tirmenstein MA, Hu CX, Scicchitano MS, Narayanan PK, McFarland DC, Thomas HC, et al. Effects of 6-hydroxydopamine on mitochondrial function and glutathione status in SH-SY5Y human neuroblastoma cells. Toxicol Vitr. 2005;19(4):471–9. doi:10.1016/j.tiv.2005.01.006.
- Henze C, Earl C, Sautter J, Schmidt N, Themann C, Hartmann A, et al. Reactive oxidative and nitrogen species in the nigrostriatal system following striatal 6-hydroxydopamine lesion in rats. Brain Res. 2005;1052(1):97–104. doi:10.1016/j.brainres.2005.06.020.
- Colla E, Jensen PH, Pletnikova O, Troncoso JC, Glabe C, Lee MK. Accumulation of toxic α-synuclein oligomer within endoplasmic reticulum occurs in a α-synucleopathy in vivo. J Neurosci. 2013;32(10):3301–5. doi:10.1523/JNEUROSCI.5368-11.2012.Accumulation doi: 10.1523/JNEUROSCI.5368-11.2012
- Smith WW, Jiang H, Pei Z, Tanaka Y, Morita H, Sawa A, et al. Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity. Hum Mol Genet. 2005;14(24):3801–11. doi:10.1093/hmg/ddi396.
- Crawford D, Le WD, Smith RG, Xie WJ, Stefani E, Appel SH. A Novel N18TG2X Mesencephalon cell hybrid expresses properties that suggest a dopaminergic cell line of substantia nigra Origin. J Neursci. 1992;12(9):3392–8. doi: 10.1523/JNEUROSCI.12-09-03392.1992
- Ryu EJ, Harding HP, Angelastro JM, Vitolo O V, Ron D, Greene LA. Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson’s disease. J Neurosci. 2002;22(24):10690–8. doi:22/24/10690 [pii] doi: 10.1523/JNEUROSCI.22-24-10690.2002
- Chan SMH, Zhao X, Elfowiris A, Ratnam C, Herbert TP. The role of de novo protein synthesis and SIRT1 in ER stress-induced Atf4 and chop mRNA expression in mammalian cells. Biochimie. 2017;138:156–67. doi:10.1016/j.biochi.2017.04.018.
- Mccullough KD, Martindale JL, Aw T, Holbrook NJ, Cullough KDMC, Klotz L. Gadd153 Sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and Perturbing the cellular redox state Gadd153 Sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and Perturbing the cellular redox state. Mol Cell Biol. 2001;21(4):1249–59. doi:10.1128/MCB.21.4.1249 doi: 10.1128/MCB.21.4.1249-1259.2001
- El-Agnaf OMA, Jakes R, Curran MD, Wallace A. Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of α-synuclein protein implicated in Parkinson’s disease. FEBS Lett. 1998;440(1–2):67–70. doi:10.1016/S0014-5793(98)01419-7.
- Yamamuro A, Yoshioka Y, Ogita K, Maeda S. Involvement of endoplasmic reticulum stress on the cell death induced by 6-hydroxydopamine in human neuroblastoma SH-SY5Y cells. Neurochem Res. 2006;31(5):657–64. doi:10.1007/s11064-006-9062-6.
- Conway KA, Lee SJ, Rochet JC, Ding TT, Harper JD, Williamson RE, et al. Accelerated oligomerization by Parkinson’s disease linked alpha-synuclein mutants. Ann N Y Acad Sci. 2000;920(617):42–45. doi:10.1111/j.1749-6632.2000.tb06903.x.
- Uversky VN, Li J, Souillac P, Millett IS, Doniach S, Jakes R, et al. Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of α-synuclein assembly by β- and γ-synucleins. J Biol Chem. 2002;277(14):11970–8. doi:10.1074/jbc.M109541200.
- Colla E, Coune P, Liu Y, Pletnikova O, Troncoso JC, Iwatsubo T, et al. Endoplasmic reticulum stress is important for the manifestations of α-synucleinopathy in vivo. J Neurosci. 2012;32(10):3306–20. doi:10.1523/JNEUROSCI.5367-11.2012.
- Conway KA, Harper JD, Lansbury PT. Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease. Nat Med. 1998;4(11):1318–20. doi:10.1038/3311.
- Narhi L, Wood SJ, Steavenson S, Jiang Y, Wu GM, Anafi D, et al. Both familial Parkinson’s disease mutations accelerate alpha-synuclein aggregation. J Biol Chem. 1999;274(14):9843–6. doi:10.1074/jbc.274.14.9843.
- Orte A, Birkett NR, Clarke RW, Devlin GL, Dobson CM, Klenerman D. Direct characterization of amyloidogenic oligomers by single-molecule fluorescence. Proc Natl Acad Sci. (USA). 2008;105(38):14424–9. doi:10.1073/pnas.0803086105.
- Eslamboli A, Romero-Ramos M, Burger C, et al. Long-term consequences of human alpha-synuclein overexpression in the primate ventral midbrain. Brain. 2007;130(3):799–815. doi:10.1093/brain/awl382.
- Masliah E. Dopaminergic Loss and Inclusion Body formation in -synuclein mice: Implications for neurodegenerative Disorders. Science. 2000;287(5456):1265–9. doi:10.1126/science.287.5456.1265.
- Jiang P, Gan M, Ebrahim A, Lin W-L, Melrose HL, Yen S-HC. ER stress response plays an important role in aggregation of α-synuclein. Mol Neurodegener. 2010;5(1):56. doi:10.1186/1750-1326-5-56.